PD-1/PD-L1 immune checkpoint inhibitors in neoadjuvant therapy for solid tumors (Review)

Tang, QY; Zhao, SK; Zhou, N; He, JL; Zu, LL; Liu, TW; Song, ZQ; Chen, J; Peng, L; Xu, S

Xu, S (通讯作者),Tianjin Med Univ, Gen Hosp, Lung Canc Inst, Dept Lung Canc Surg, 154 Anshan Rd, Tianjin 300052, Peoples R China.;Peng, L (通讯作者),Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Dept Resp Dis, 158 Shangtang Rd, Hangzhou 310000, Zhejiang, Peoples R China.

INTERNATIONAL JOURNAL OF ONCOLOGY, 2023; 62 (4):

Abstract

A comprehensive search regarding programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitor monotherapy or combination therapy......

Full Text Link